465 related articles for article (PubMed ID: 23417041)
1. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Pernow J; Jung C
Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
[TBL] [Abstract][Full Text] [Related]
2. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Durante W; Johnson FK; Johnson RA
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
4. Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
Martens CR; Kuczmarski JM; Lennon-Edwards S; Edwards DG
J Cardiovasc Pharmacol; 2014 Jan; 63(1):40-8. PubMed ID: 24084210
[TBL] [Abstract][Full Text] [Related]
5. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
[TBL] [Abstract][Full Text] [Related]
6. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
Dhar I; Dhar A; Wu L; Desai K
J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
[TBL] [Abstract][Full Text] [Related]
7. Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.
Kövamees O; Shemyakin A; Checa A; Wheelock CE; Lundberg JO; Östenson CG; Pernow J
J Clin Endocrinol Metab; 2016 Nov; 101(11):3952-3958. PubMed ID: 27399350
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.
Gao X; Xu X; Belmadani S; Park Y; Tang Z; Feldman AM; Chilian WM; Zhang C
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1269-75. PubMed ID: 17413034
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.
Bagnost T; Ma L; da Silva RF; Rezakhaniha R; Houdayer C; Stergiopulos N; André C; Guillaume Y; Berthelot A; Demougeot C
Cardiovasc Res; 2010 Aug; 87(3):569-77. PubMed ID: 20219858
[TBL] [Abstract][Full Text] [Related]
10. Vascular arginase contributes to arteriolar endothelial dysfunction in a rat model of hemorrhagic shock.
Johnson RA; Durante W; Craig T; Peyton KJ; Myers JG; Stewart RM; Johnson FK
J Trauma; 2010 Aug; 69(2):384-91. PubMed ID: 20699748
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase activation through obacunone-dependent arginase inhibition restored impaired endothelial function in ApoE-null mice.
Yoon J; Park M; Lee Jh; Min BS; Ryoo S
Vascul Pharmacol; 2014 Mar; 60(3):102-9. PubMed ID: 24509132
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles.
Thengchaisri N; Hein TW; Wang W; Xu X; Li Z; Fossum TW; Kuo L
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2035-42. PubMed ID: 16794224
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases.
Roe ND; Ren J
Vascul Pharmacol; 2012; 57(5-6):168-72. PubMed ID: 22361333
[TBL] [Abstract][Full Text] [Related]
15. Arginase Inhibitor 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside Activates Endothelial Nitric Oxide Synthase and Improves Vascular Function.
Yi B; Nguyen MC; Won MH; Kim YM; Ryoo S
Planta Med; 2017 Feb; 83(3-04):210-216. PubMed ID: 27392245
[TBL] [Abstract][Full Text] [Related]
16. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
Hoang HH; Padgham SV; Meininger CJ
Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):76-82. PubMed ID: 23164986
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase.
Hein TW; Zhang C; Wang W; Chang CI; Thengchaisri N; Kuo L
FASEB J; 2003 Dec; 17(15):2328-30. PubMed ID: 14563685
[TBL] [Abstract][Full Text] [Related]
18. Arginase and vascular aging.
Santhanam L; Christianson DW; Nyhan D; Berkowitz DE
J Appl Physiol (1985); 2008 Nov; 105(5):1632-42. PubMed ID: 18719233
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
20. Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.
Bhatta A; Yao L; Xu Z; Toque HA; Chen J; Atawia RT; Fouda AY; Bagi Z; Lucas R; Caldwell RB; Caldwell RW
Cardiovasc Res; 2017 Nov; 113(13):1664-1676. PubMed ID: 29048462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
